Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
about
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@ast
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@en
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@nl
type
label
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@ast
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@en
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@nl
prefLabel
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@ast
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@en
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@nl
P2093
P2860
P1433
P1476
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
@en
P2093
Gary L Johnson
John E Scott
Mike Tarpley
Temesgen T Abdissa
P2860
P304
P407
P577
2014-04-01T00:00:00Z